QTMeds

Drug Database Monograph

TYRUKO 300 mg

PENDING REVIEW

Active Ingredient: NATALIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 60779570

← Back to Prescription Analyzer